BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kudo M. Local ablation therapy for hepatocellular carcinoma: current status and future perspectives. J Gastroenterol. 2004;39:205-214. [PMID: 15064996 DOI: 10.1007/s00535-003-1280-y] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Kei SK, Rhim H, Choi D, Lee WJ, Lim HK, Kim YS. Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence. AJR Am J Roentgenol. 2008;190:1544-1551. [PMID: 18492905 DOI: 10.2214/ajr.07.2798] [Cited by in Crossref: 65] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
2 Ueno M, Hayami S, Shigekawa Y, Kawai M, Hirono S, Okada K, Tamai H, Shingaki N, Mori Y, Ichinose M, Yamaue H. Prognostic impact of surgery and radiofrequency ablation on single nodular HCC ⩽5 cm: Cohort study based on serum HCC markers. Journal of Hepatology 2015;63:1352-9. [DOI: 10.1016/j.jhep.2015.07.013] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
3 Abu Elyazed MM, Abdullah MA. Thoracic paravertebral block for the anesthetic management of percutaneous radiofrequency ablation of liver tumors. J Anaesthesiol Clin Pharmacol 2018;34:166-71. [PMID: 30104822 DOI: 10.4103/joacp.JOACP_39_17] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Mast TD, Pucke DP, Subramanian SE, Bowlus WJ, Rudich SM, Buell JF. Ultrasound Monitoring of In Vitro Radio Frequency Ablation by Echo Decorrelation Imaging. Journal of Ultrasound in Medicine 2008;27:1685-97. [DOI: 10.7863/jum.2008.27.12.1685] [Cited by in Crossref: 40] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
5 Lu MD, Xu HX, Xie XY, Yin XY, Chen JW, Kuang M, Xu ZF, Liu GJ, Zheng YL. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol. 2005;40:1054-1060. [PMID: 16322950 DOI: 10.1007/s00535-005-1671-3] [Cited by in Crossref: 160] [Cited by in F6Publishing: 134] [Article Influence: 10.7] [Reference Citation Analysis]
6 Ruzzenente A, Guglielmi A, Sandri M, Campagnaro T, Valdegamberi A, Conci S, Bagante F, Turcato G, D'Onofrio M, Iacono C. Surgical resection versus local ablation for HCC on cirrhosis: results from a propensity case-matched study. J Gastrointest Surg. 2012;16:301-11; discussion 311. [PMID: 22095524 DOI: 10.1007/s11605-011-1745-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
7 Minami Y, Kudo M, Chung H, Inoue T, Takahashi S, Hatanaka K, Ueda T, Hagiwara H, Kitai S, Ueshima K, Fukunaga T, Shiozaki H. Percutaneous radiofrequency ablation of sonographically unidentifiable liver tumors. Feasibility and usefulness of a novel guiding technique with an integrated system of computed tomography and sonographic images. Oncology 2007;72 Suppl 1:111-6. [PMID: 18087191 DOI: 10.1159/000111716] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
8 Kudo M. Diagnostic imaging of hepatocellular carcinoma: Recent progress. Oncology. 2011;81 Suppl 1:73-85. [PMID: 22212940 DOI: 10.1159/000333265] [Cited by in Crossref: 49] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
9 Morimoto N, Isoda N, Watanabe S, Otake T, Hirosawa T, Tsukui M, Miyata N, Murayama K, Iwashita C, Takaoka Y, Yamamoto H. A case of small hepatocellular carcinoma treated with laparoscopic multipolar radiofrequency ablation with a no-touch ablation procedure. Clin J Gastroenterol 2014;7:510-5. [PMID: 25491908 DOI: 10.1007/s12328-014-0531-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
10 Pucci C, Martinelli C, Ciofani G. Innovative approaches for cancer treatment: current perspectives and new challenges. Ecancermedicalscience 2019;13:961. [PMID: 31537986 DOI: 10.3332/ecancer.2019.961] [Cited by in Crossref: 75] [Cited by in F6Publishing: 46] [Article Influence: 37.5] [Reference Citation Analysis]
11 Solmi L, Nigro G, Roda E. Therapeutic effectiveness of echo-guided percutaneous radiofrequency ablation therapy with a LeVeen needle electrode in hepatocellular carcinoma. World J Gastroenterol 2006;12:1098-104. [PMID: 16534852 DOI: 10.3748/wjg.v12.i7.1098] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
12 Takeyama N, Mizobuchi N, Sakaki M, Shimozuma Y, Munechika J, Kajiwara A, Uchikoshi M, Uozumi S, Ohgiya Y, Gokan T. Evaluation of hepatocellular carcinoma ablative margins using fused pre- and post-ablation hepatobiliary phase images. Abdom Radiol 2019;44:923-35. [DOI: 10.1007/s00261-018-1800-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
13 Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, Rossi S. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology. 2008;47:82-89. [PMID: 18008357 DOI: 10.1002/hep.21933] [Cited by in Crossref: 705] [Cited by in F6Publishing: 603] [Article Influence: 54.2] [Reference Citation Analysis]
14 Liu Y, Zheng Y, Li S, Li B, Zhang Y, Yuan Y. Percutaneous microwave ablation of larger hepatocellular carcinoma. Clin Radiol. 2013;68:21-26. [PMID: 22766484 DOI: 10.1016/j.crad.2012.05.007] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 6.6] [Reference Citation Analysis]
15 Chen S, Shi M, Shen L, Qi H, Wan W, Cao F, Xie L, Wu Y, Chen G, Mo J, Zhu G, Ye D, Zhang Y, Feng Z, Xu L, Fan W. Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J Hyperthermia 2020;37:384-91. [PMID: 32323585 DOI: 10.1080/02656736.2020.1752400] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ahn SJ, Lee JM, Lee DH, Lee SM, Yoon JH, Kim YJ, Lee JH, Yu SJ, Han JK. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma. J Hepatol. 2017;66:347-354. [PMID: 27650284 DOI: 10.1016/j.jhep.2016.09.003] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 10.4] [Reference Citation Analysis]
17 Massarweh NN, Park JO, Yeung RS, Flum DR. Comparative assessment of the safety and effectiveness of radiofrequency ablation among elderly medicare beneficiaries with hepatocellular carcinoma. Ann Surg Oncol 2012;19:1058-65. [PMID: 21947695 DOI: 10.1245/s10434-011-2067-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
18 Asahina Y, Nakanishi H, Izumi N. Laparoscopic radiofrequency ablation for hepatocellular carcinoma. Dig Endosc. 2009;21:67-72. [PMID: 19691776 DOI: 10.1111/j.1443-1661.2009.00844.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
19 Minami Y, Kudo M, Chung H, Kawasaki T, Yagyu Y, Shimono T, Shiozaki H. Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial. AJR Am J Roentgenol 2007;188:489-94. [PMID: 17242259 DOI: 10.2214/AJR.05.1286] [Cited by in Crossref: 57] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
20 Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: a literature review. Int J Hepatol. 2011;2011:104685. [PMID: 21994847 DOI: 10.4061/2011/104685] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 5.4] [Reference Citation Analysis]
21 Maeda T, Hong J, Konishi K, Nakatsuji T, Yasunaga T, Yamashita Y, Taketomi A, Kotoh K, Enjoji M, Nakashima H, Tanoue K, Maehara Y, Hashizume M. Tumor ablation therapy of liver cancers with an open magnetic resonance imaging-based navigation system. Surg Endosc 2009;23:1048-53. [PMID: 18813998 DOI: 10.1007/s00464-008-0123-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
22 Xu ZF, Xie XY, Kuang M, Liu GJ, Chen LD, Zheng YL, Lu MD. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance. J Clin Ultrasound. 2014;42:321-330. [PMID: 24615771 DOI: 10.1002/jcu.22141] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
23 El-Fattah MA, Aboelmagd M, Elhamouly M. Prognostic factors of hepatocellular carcinoma survival after radiofrequency ablation: A US population-based study. United European Gastroenterol J 2017;5:227-35. [PMID: 28344790 DOI: 10.1177/2050640616659024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
24 Huang G, Lin M, Xie X, Liu B, Xu Z, Lencioni R, Lu M, Kuang M. Combined radiofrequency ablation and ethanol injection with a multipronged needle for the treatment of medium and large hepatocellular carcinoma. Eur Radiol 2014;24:1565-71. [PMID: 24788036 DOI: 10.1007/s00330-014-3151-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
25 Nakamura M, Hayami S, Ueno M, Kawai M, Miyamoto A, Suzaki N, Hirono S, Okada KI, Miyazawa M, Kitahata Y, Yamaue H. Detection of needle tract implantation and peritoneal seeding after radiofrequency ablation using intraoperative near-infrared fluorescence system for recurrent hepatocellular carcinoma: a case report. Surg Case Rep 2018;4:76. [PMID: 30003446 DOI: 10.1186/s40792-018-0485-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
26 Hirooka M, Koizumi Y, Tanaka T, Sunago K, Nakamura Y, Watanabe T, Yoshida O, Tokumoto Y, Abe M, Hiasa Y. Radiofrequency Ablation Covering the Entire Tumor Blood Drainage Area Improves Survival in Hepatocellular Carcinoma. Hepatol Commun 2021;5:1300-9. [PMID: 34278177 DOI: 10.1002/hep4.1703] [Reference Citation Analysis]
27 Lee SH, Jin YJ, Lee JW. Survival benefit of radiofrequency ablation for solitary (3-5 cm) hepatocellular carcinoma: An analysis for nationwide cancer registry. Medicine (Baltimore) 2017;96:e8486. [PMID: 29095307 DOI: 10.1097/MD.0000000000008486] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
28 Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: Current status. World J Radiol. 2010;2:417-424. [PMID: 21179308 DOI: 10.4329/wjr.v2.ill.417] [Reference Citation Analysis]
29 Kariyama K, Nouso K, Wakuta A, Oonishi A, Toyoda H, Tada T, Hiraoka A, Tsuji K, Itobayashi E, Ishikawa T, Takaguchi K, Tsutsui A, Shimada N, Kumada T. Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies. Liver Cancer 2020;9:41-9. [PMID: 32071908 DOI: 10.1159/000502479] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
30 Kalra N, Gupta P, Chawla Y, Khandelwal N. Locoregional treatment for hepatocellular carcinoma: The best is yet to come. World J Radiol. 2015;7:306-318. [PMID: 26516427 DOI: 10.4329/wjr.v7.i10.306] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
31 Minami Y, Kudo M. Contrast-enhanced harmonic ultrasound imaging in ablation therapy for primary hepatocellular carcinoma. World J Radiol 2009;1:86-91. [PMID: 21160724 DOI: 10.4329/wjr.v1.i1.86] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
32 Carasso D, Eliav U, Navon G. Nuclear magnetic resonance parameters for monitoring coagulation of liver tissue. Magn Reson Med 2005;54:1082-6. [DOI: 10.1002/mrm.20693] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
33 Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: Current status. World J Radiol. 2010;2:417-424. [PMID: 21179308 DOI: 10.4329/wjr.v2.i11.417] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 50] [Article Influence: 6.0] [Reference Citation Analysis]
34 Minami Y, Minami T, Ueshima K, Yagyu Y, Tsurusaki M, Okada T, Hori M, Kudo M, Murakami T. Three-Dimensional Radiological Assessment of Ablative Margins in Hepatocellular Carcinoma: Pilot Study of Overlay Fused CT/MRI Imaging with Automatic Registration. Cancers (Basel) 2021;13:1460. [PMID: 33806751 DOI: 10.3390/cancers13061460] [Reference Citation Analysis]
35 Kudo M. Defect Reperfusion Imaging with Sonazoid®: A Breakthrough in Hepatocellular Carcinoma. Liver Cancer 2016;5:1-7. [PMID: 26989655 DOI: 10.1159/000367760] [Cited by in Crossref: 4] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
36 Itoh S, Ikeda Y, Kawanaka H, Okuyama T, Kawasaki K, Eguchi D, Korenaga D, Takenaka K. Efficacy of surgical microwave therapy in patients with unresectable hepatocellular carcinoma. Ann Surg Oncol. 2011;18:3650-3656. [PMID: 21674268 DOI: 10.1245/s10434-011-1831-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
37 Hong HP, Lee JY, Lee MY, Jung KU, Kim BI, Son BH, Shin JH, Lee SR. Early experience with laparoscopic treatment of liver tumors using a separable cluster electrode with a no-touch technique. Wideochir Inne Tech Maloinwazyjne 2021;16:76-82. [PMID: 33786119 DOI: 10.5114/wiitm.2020.95065] [Reference Citation Analysis]
38 Grosso M, Vignali C, Quaretti P, Nicolini A, Melchiorre F, Gallarato G, Bargellini I, Petruzzi P, Massa Saluzzo C, Crespi S. Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study. Cardiovasc Intervent Radiol. 2008;31:1141-1149. [PMID: 18696150 DOI: 10.1007/s00270-008-9409-2] [Cited by in Crossref: 85] [Cited by in F6Publishing: 71] [Article Influence: 6.5] [Reference Citation Analysis]
39 Minami Y, Kudo M. Imaging Modalities for Assessment of Treatment Response to Nonsurgical Hepatocellular Carcinoma Therapy: Contrast-Enhanced US, CT, and MRI. Liver Cancer 2015;4:106-14. [PMID: 26697413 DOI: 10.1159/000367733] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
40 Chu HH, Kim JH, Yoon HK, Ko HK, Gwon DI, Kim PN, Sung KB, Ko GY, Kim SY, Park SH. Chemoembolization Combined with Radiofrequency Ablation for Medium-Sized Hepatocellular Carcinoma: A Propensity-Score Analysis. J Vasc Interv Radiol. 2019;30:1533-1543. [PMID: 31471190 DOI: 10.1016/j.jvir.2019.06.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 7.5] [Reference Citation Analysis]
41 Kudo M, Kubo S, Takayasu K, Sakamoto M, Tanaka M, Ikai I, Furuse J, Nakamura K, Makuuchi M; Liver Cancer Study Group of Japan (Committee for Response Evaluation Criteria in Cancer of the Liver, Liver Cancer Study Group of Japan). Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version). Hepatol Res. 2010;40:686-692. [PMID: 20633194 DOI: 10.1111/j.1872-034x.2010.00674.x] [Cited by in Crossref: 93] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
42 Kudo M, Sakaguchi Y, Chung H, Hatanaka K, Hagiwara S, Ishikawa E, Takahashi S, Kitai S, Inoue T, Minami Y. Long-term interferon maintenance therapy improves survival in patients with HCV-related hepatocellular carcinoma after curative radiofrequency ablation. A matched case-control study. Oncology. 2007;72 Suppl 1:132-138. [PMID: 18087194 DOI: 10.1159/000111719] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
43 Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242:158-171. [PMID: 16041205 DOI: 10.1097/01.sla.0000171032.99149.fe] [Cited by in Crossref: 503] [Cited by in F6Publishing: 416] [Article Influence: 31.4] [Reference Citation Analysis]
44 Matthew Hawkins C, Towbin AJ, Roebuck DJ, Monroe EJ, Gill AE, Thakor AS, Towbin RB, Cahill AM, Lungren MP. Role of interventional radiology in managing pediatric liver tumors: Part 2: percutaneous interventions. Pediatr Radiol 2018;48:565-80. [DOI: 10.1007/s00247-018-4072-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
45 Minami Y, Kudo M. Radiofrequency ablation of liver metastases from colorectal cancer: a literature review. Gut Liver 2013;7:1-6. [PMID: 23422905 DOI: 10.5009/gnl.2013.7.1.1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
46 Nishikawa H, Kimura T, Kita R, Osaki Y. Radiofrequency ablation for hepatocellular carcinoma. Int J Hyperthermia. 2013;29:558-568. [PMID: 23937321 DOI: 10.3109/02656736.2013.821528] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 5.8] [Reference Citation Analysis]
47 Sakaguchi Y, Kudo M, Fukunaga T, Minami Y, Chung H, Kawasaki T. Low-dose, long-term, intermittent interferon-alpha-2b therapy after radical treatment by radiofrequency ablation delays clinical recurrence in patients with hepatitis C virus-related hepatocellular carcinoma. Intervirology. 2005;48:64-70. [PMID: 15785092 DOI: 10.1159/000082097] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 2.4] [Reference Citation Analysis]
48 Zhou P, Kudo M, Minami Y, Chung H, Inoue T, Fukunaga T, Maekawa K. What is the best time to evaluate treatment response after radiofrequency ablation of hepatocellular carcinoma using contrast-enhanced sonography? Oncology. 2007;72 Suppl 1:92-97. [PMID: 18087188 DOI: 10.1159/000111713] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
49 Yang PC, Lin BR, Chen YC, Lin YL, Lai HS, Huang KW, Liang JT. Local Control by Radiofrequency Thermal Ablation Increased Overall Survival in Patients With Refractory Liver Metastases of Colorectal Cancer. Medicine (Baltimore) 2016;95:e3338. [PMID: 27057913 DOI: 10.1097/MD.0000000000003338] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Minami Y, Chung H, Kudo M, Kitai S, Takahashi S, Inoue T, Ueshima K, Shiozaki H. Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation. AJR Am J Roentgenol 2008;190:W335-41. [PMID: 18492875 DOI: 10.2214/AJR.07.3092] [Cited by in Crossref: 81] [Cited by in F6Publishing: 23] [Article Influence: 6.2] [Reference Citation Analysis]
51 Hirooka M, Ochi H, Koizumi Y, Tokumoto Y, Hiraoka A, Kumagi T, Abe M, Tanaka H, Hiasa Y. Local recurrence of hepatocellular carcinoma in the tumor blood drainage area following radiofrequency ablation. Mol Clin Oncol 2014;2:182-6. [PMID: 24649330 DOI: 10.3892/mco.2013.229] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
52 Jeong YS, Kim SH, Lee JM, Lee JY, Kim JH, Lee DH, Kang HJ, Yoon CJ, Han JK. Gastrointestinal tract complications after hepatic radiofrequency ablation: CT prediction for major complications. Abdom Radiol (NY). 2018;43:583-592. [PMID: 28676999 DOI: 10.1007/s00261-017-1239-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
53 Mast TD, Barthe PG, Makin IR, Slayton MH, Karunakaran CP, Burgess MT, Alqadah A, Rudich SM. Treatment of rabbit liver cancer in vivo using miniaturized image-ablate ultrasound arrays. Ultrasound Med Biol 2011;37:1609-21. [PMID: 21821349 DOI: 10.1016/j.ultrasmedbio.2011.05.850] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
54 Mlynarsky L, Menachem Y, Shibolet O. Treatment of hepatocellular carcinoma: Steps forward but still a long way to go. World J Hepatol 2015;7:566-74. [PMID: 25848480 DOI: 10.4254/wjh.v7.i3.566] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
55 Hiraoka A, Kumagi T, Hirooka M, Uehara T, Kurose K, Iuchi H, Hiasa Y, Matsuura B, Michitaka K, Kumano S, Tanaka H, Yamashita Y, Horiike N, Mochizuki T, Onji M. Prognosis following transcatheter arterial embolization for 121 patients with unresectable hepatocellular carcinoma with or without a history of treatment. World J Gastroenterol 2006;12:2075-9. [PMID: 16610060 DOI: 10.3748/wjg.v12.i13.2075] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
56 Minami Y, Nishida N, Kudo M. Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI. World J Gastroenterol. 2014;20:4160-4166. [PMID: 24764654 DOI: 10.3748/wjg.v20.i15.4160] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
57 Itoh S, Morita K, Ueda S, Sugimachi K, Yamashita Y, Gion T, Fukuzawa K, Wakasugi K, Taketomi A, Maehara Y. Long-term results of hepatic resection combined with intraoperative local ablation therapy for patients with multinodular hepatocellular carcinomas. Ann Surg Oncol. 2009;16:3299-3307. [PMID: 19826875 DOI: 10.1245/s10434-009-0721-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]